Key result
EuroSCORE II predicts short-term mortality in Taiwanese cardiac surgery patients with an AUC of ~0.83.
Why the study?
EuroSCORE II is well-accepted for mortality risk evaluation in cardiac surgery in Europe, but its performance in Taiwanese patients needed to be determined.
Does the EuroSCORE II model accurately predict short-term mortality in Taiwanese patients undergoing general cardiac surgery?
Observational (n=657)
No
Does the EuroSCORE II model accurately predict short-term mortality in Taiwanese patients undergoing general cardiac surgery?
The EuroSCORE II model performs well in predicting short-term mortality for Taiwanese patients undergoing cardiac surgery, with in-hospital mortality serving as a better endpoint than 30-day mortality.
Answers are grounded in this paper and cite their sources.
Supports EuroSCORE II for short-term mortality prediction in Taiwanese patients; extends validation to Asian cohorts but leaves practice change open.
Background: The latest European System for Cardiac Operative Risk Evaluation (EuroSCORE) II is a well-accepted risk evaluation system for mortality in cardiac surgery in Europe. Objectives: To determine the performance of this new model in Taiwanese patients. Methods: Between January 2012 and December 2014, 657 patients underwent cardiac surgery at our institution. The EuroSCORE II scores of all patients were determined preoperatively. The short-term surgical outcomes of 30-day and in-hospital mortality were evaluated to assess the performance of the EuroSCORE II. Results: Of the 657 patients [192 women (29.22%); age 63.5 ± 12.68 years], the 30-day mortality rate was 5.48%, and the in-hospital mortality rate was 9.28%. The discrimination power of this new model was good in all populations, regardless of 30-day mortality or in-hospital mortality. Good accuracy was also noted in different procedures related to coronary artery bypass grafting, and good calibration was noted for cardiac procedures (p value > 0.05). When predicting surgical death within 30 days, the EuroSCORE II overestimated the risk (observed to expected: 0.79), but in-hospital mortality was underestimated (observed to expected: 1.33). The predictive ability [area under the curve (AUC) of the receiver operating characteristic (ROC) curve] and calibration of the EuroSCORE II for 30-day mortality (0.792) and in-hospital mortality (0.825) suggested that in-hospital mortality is a better endpoint for the EuroSCORE II. Conclusions: The new EuroSCORE II model performed well in predicting short-term outcomes among patients undergoing general cardiac surgeries. For short-term outcomes, in-hospital mortality was better than 30-day mortality as an indicator of surgical results, suggesting that it may be a better endpoint for the EuroSCORE II.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) conducted an observational in Cardiac surgery (n=657). EuroSCORE II was evaluated on 30-day and in-hospital mortality (AUC 0.792 (30-day) and 0.825 (in-hospital)). The EuroSCORE II model demonstrated good predictive ability for short-term mortality in Taiwanese cardiac surgery patients, with an AUC of 0.792 for 30-day and 0.825 for in-hospital mortality.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: